PlainRecalls
FDA Drug Moderate Class II Terminated

Losartan Potassium Tablets USP 25 mg 1000 count bottle NDC 60429-316-10 Rx only GSMS Incorporated

Reported: May 29, 2019 Initiated: May 1, 2019 #D-1284-2019

Product Description

Losartan Potassium Tablets USP 25 mg 1000 count bottle NDC 60429-316-10 Rx only GSMS Incorporated

Reason for Recall

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer

Details

Units Affected
11,286 HDPE Bottles
Distribution
IL, MI, MN, PA, TN, TX. Two (2) US government and one (1) Veterans Affairs accounts. No foreign accounts.
Location
Camarillo, CA

Frequently Asked Questions

What product was recalled?
Losartan Potassium Tablets USP 25 mg 1000 count bottle NDC 60429-316-10 Rx only GSMS Incorporated. Recalled by Golden State Medical Supply Inc.. Units affected: 11,286 HDPE Bottles.
Why was this product recalled?
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer
Which agency issued this recall?
This recall was issued by the FDA Drug on May 29, 2019. Severity: Moderate. Recall number: D-1284-2019.